Tag Archives: Diabetes
-
-
FDA Avandia Panel Member Found to Have Received Fees from Drug Maker
-
Blood Pressure Drug Cancer Concerns Lead to FDA Safety Review
-
FDA Panel Does Not Recommend Avandia Recall, Despite Heart Risks
-
Settlement of Avandia Lawsuits Reached in About 10,000 More Cases
-
Avandia Heart Attack Study Data Concealed by Glaxo in 2001: FDA Reviewer
-
Side Effects of Avandia Have FDA Reviewers Split Before Key Meeting
-
Januvia, Byetta Pancreatitis Risk Not Seen in New Study
-
Avandia Recall May be Recommended by FDA Panel Next Month
-
Problems with Avandia Continue to Mount for GlaxoSmithKline